324 studies found for:    "Idiopathic pulmonary hypertension"
Show Display Options
Rank Status Study
21 Completed
Has Results
Iloprost Power 15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: iloprost (5 µg);   Drug: placebo
22 Completed Pulmonary Arterial Hypertension in Children
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: bosentan
23 Recruiting Rituximab for Treatment of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension (SSc-PAH)
Condition: Systemic Sclerosis-Associated Pulmonary Arterial Hypertension
Interventions: Biological: Rituximab;   Other: Placebo
24 Terminated Study of Intravenous Remodulin in Patients in India With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Remodulin (treprostinil sodium)
25 Completed
Has Results
Safety Study Extension of Iloprost Power 15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: iloprost
26 Completed
Has Results
Evaluate The Clinical Effectiveness, Safety And Tolerability Of Sildenafil Used In Doses ≥20mg TID For The Treatment Of Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sildenafil citrate
27 Recruiting Bardoxolone Methyl Evaluation in Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Bardoxolone methyl;   Drug: Placebo
28 Completed
Has Results
Epoprostenol for Injection in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: ACT-385781A (Actelion Epoprostenol);   Drug: Flolan®
29 Active, not recruiting Extension to CQTI571A2102 to Evaluate Long-term Safety, Tolerability and Efficacy of Imatinib in Severe Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Imatinib
30 Active, not recruiting Long-term Extension Study of the SERAPHIN Study, to Assess the Safety and Tolerability of ACT 064992 in Patients With Symptomatic Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: ACT-064992
31 Completed 6R-BH4 Pulmonary Arterial Hypertension Study
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: sapropterin dihydrochloride (6R-BH4)
32 Unknown  Pulmonary Arterial Hypertension Secondary to Idiopathic Pulmonary Fibrosis And Treatment With Sildenafil
Conditions: Pulmonary Arterial Hypertension;   Idiopathic Pulmonary Fibrosis;   Interstitial Lung Disease;   Pulmonary Hypertension
Intervention: Drug: sildenafil
33 Active, not recruiting Selexipag (ACT-293987) in Pulmonary Arterial Hypertension, GRIPHON Trial
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Selexipag (ACT-293987);   Drug: Placebo
34 Terminated
Has Results
Iloprost Power Disc-15 in Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Iloprost PD-6;   Drug: Iloprost PD-15
35 Completed Sorafenib Study: Dosing in Patients With Pulmonary Arterial Hypertension (PAH)
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Sorafenib
36 Completed
Has Results
Study of Macitentan (ACT-064992) on Morbidity and Mortality in Patients With Symptomatic Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: macitentan (ACT-064992);   Drug: placebo
37 Recruiting Beta Blockers for Treatment of Pulmonary Arterial Hypertension in Children
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: Carvedilol
38 Completed Proof of Concept Study of IMMUNOadsorption Therapy in Patients With Idiopathic Pulmonary Arterial Hypertension
Condition: Idiopathic Pulmonary Arterial Hypertension
Intervention: Device: TheraSorb® - Ig flex
39 Terminated Long-term Study of AIR001 in Subjects With WHO Group 1 Pulmonary Arterial Hypertension Who Completed AIR001-CS05
Condition: Pulmonary Arterial Hypertension
Intervention: Drug: AIR001
40 Completed Safety and Efficacy of Imatinib Mesylate in Patients With Pulmonary Arterial Hypertension
Condition: Pulmonary Arterial Hypertension
Interventions: Drug: Imatinib mesylate;   Drug: Placebo

Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results
Indicates status has not been verified in more than two years